The impact of obesity on SLE disease activity: findings from the Southern California Lupus Registry (SCOLR).


Journal

Clinical rheumatology
ISSN: 1434-9949
Titre abrégé: Clin Rheumatol
Pays: Germany
ID NLM: 8211469

Informations de publication

Date de publication:
Feb 2019
Historique:
received: 23 07 2018
accepted: 10 10 2018
revised: 18 09 2018
pubmed: 26 10 2018
medline: 29 5 2019
entrez: 26 10 2018
Statut: ppublish

Résumé

The role of obesity in systemic lupus erythematosus (SLE) remains controversial. Studies have linked adiposity with a heightened risk of clinical complications including neurocognitive decline, renal impairment, dampened physical activity, and depressed quality of life-but not disease activity. We aimed to reexamine whether obesity in SLE patients independently associates with higher disease activity. Adult patients with SLE were recruited from the longitudinal, multi-ethnic Southern California Lupus Registry (SCOLR). Disease status was ascertained by calculating SLE Disease Activity Index (SLEDAI), which was then statistically analyzed for association with increased body mass index (BMI) by univariable and multivariable regression analyses. One hundred and thirty-seven patients were included in the study; 37% were obese (BMI ≥ 30 kg/m

Identifiants

pubmed: 30357495
doi: 10.1007/s10067-018-4336-3
pii: 10.1007/s10067-018-4336-3
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

597-600

Références

J Inflamm (Lond). 2005 Mar 21;2(1):2
pubmed: 15813957
Arthritis Rheum. 2005 Nov;52(11):3651-9
pubmed: 16258902
Ann Rheum Dis. 2007 Feb;66(2):208-14
pubmed: 16901956
Ann Rheum Dis. 2007 May;66(5):618-22
pubmed: 17107981
J Clin Rheumatol. 2007 Jun;13(3):128-33
pubmed: 17551377
Curr Rheumatol Rep. 2009 Aug;11(4):248-54
pubmed: 19691927
Arthritis Care Res (Hoboken). 2011 Oct;63(10):1357-64
pubmed: 21702085
Autoimmun Rev. 2012 Jun;11(8):593-5
pubmed: 22041578
Clin Rheumatol. 2012 Apr;31(4):669-75
pubmed: 22193369
Int J Rheum Dis. 2012 Jun;15(3):261-7
pubmed: 22212605
J Immunol. 2012 Mar 1;188(5):2070-3
pubmed: 22291185
Arthritis Care Res (Hoboken). 2012 Apr;64(4):502-10
pubmed: 22337564
Arthritis Rheum. 2012 Aug;64(8):2677-86
pubmed: 22553077
Am J Epidemiol. 2012 Oct 15;176(8):708-19
pubmed: 23024137
J Immunol. 2013 Apr 1;190(7):3054-8
pubmed: 23447682
Curr Opin Rheumatol. 2013 Sep;25(5):597-605
pubmed: 23846339
Clin Immunol. 2013 Dec;149(3):530-3
pubmed: 24263282
J Immunol. 2014 Feb 1;192(3):979-84
pubmed: 24391210
Autoimmun Rev. 2014 Sep;13(9):981-1000
pubmed: 25092612

Auteurs

Phildrich Teh (P)

Department of Internal Medicine, University of California Riverside, 900 University Ave, Riverside, CA, 92521, USA.

Bishoy Zakhary (B)

Office of Research, Riverside University Health System, 26520 Cactus Avenue - Education Building, Moreno Valley, CA, 92555, USA.

Vaneet K Sandhu (VK)

Department of Internal Medicine, Division of Rheumatology, Loma Linda University, 11234 Anderson Street, Suite 1521, Loma Linda, CA, 92354, USA. vksandhu@llu.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH